TABLE 1 North America Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 2 North America Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 3 North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 4 North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 5 North America Aflibercept Market by Country, 2019 - 2022, USD Million
TABLE 6 North America Aflibercept Market by Country, 2023 - 2030, USD Million
TABLE 7 North America Ranibizumab Market by Country, 2019 - 2022, USD Million
TABLE 8 North America Ranibizumab Market by Country, 2023 - 2030, USD Million
TABLE 9 North America Others Market by Country, 2019 - 2022, USD Million
TABLE 10 North America Others Market by Country, 2023 - 2030, USD Million
TABLE 11 North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 12 North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 13 North America Wet Market by Country, 2019 - 2022, USD Million
TABLE 14 North America Wet Market by Country, 2023 - 2030, USD Million
TABLE 15 North America Dry Market by Country, 2019 - 2022, USD Million
TABLE 16 North America Dry Market by Country, 2023 - 2030, USD Million
TABLE 17 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 18 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 19 North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 20 North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 21 North America Retail Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 22 North America Retail Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 23 North America Online Pharmacy Market by Country, 2019 - 2022, USD Million
TABLE 24 North America Online Pharmacy Market by Country, 2023 - 2030, USD Million
TABLE 25 North America Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2022, USD Million
TABLE 26 North America Age Related Macular Degeneration (AMD) Market by Country, 2023 - 2030, USD Million
TABLE 27 US Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 28 US Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 29 US Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 30 US Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 31 US Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 32 US Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 33 US Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 34 US Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 35 Canada Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 36 Canada Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 37 Canada Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 38 Canada Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 39 Canada Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 40 Canada Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 41 Canada Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 42 Canada Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 43 Mexico Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 44 Mexico Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 45 Mexico Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 46 Mexico Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 47 Mexico Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 48 Mexico Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 49 Mexico Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 50 Mexico Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 51 Rest of North America Age Related Macular Degeneration (AMD) Market, 2019 - 2022, USD Million
TABLE 52 Rest of North America Age Related Macular Degeneration (AMD) Market, 2023 - 2030, USD Million
TABLE 53 Rest of North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2022, USD Million
TABLE 54 Rest of North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2023 - 2030, USD Million
TABLE 55 Rest of North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2022, USD Million
TABLE 56 Rest of North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2023 - 2030, USD Million
TABLE 57 Rest of North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 58 Rest of North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2023 - 2030, USD Million
TABLE 59 Key Information – Biogen, Inc.
TABLE 60 Key Information – Bayer AG
TABLE 61 Key Information – Apellis Pharmaceuticals, Inc.
TABLE 62 Key Information – Regeneron Pharmaceuticals, Inc.
TABLE 63 Key Information – F. Hoffmann-La Roche Ltd.
TABLE 64 Key information – Ionis Pharmaceuticals, Inc.
TABLE 65 Key Information – Novartis AG
TABLE 66 Key Information – Sanofi S.A.
TABLE 67 Key Information – Coherus Biosciences, Inc.
TABLE 68 key information – Bausch Health Companies, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Age Related Macular Degeneration (AMD) Market, 2019 - 2030, USD Million
FIG 3 Key Factors Impacting Age Related Macular Degeneration (AMD)Market
FIG 4 Porter’s Five Forces Analysis – Age Related Macular Degeneration (AMD) Market
FIG 5 North America Age Related Macular Degeneration (AMD) Market share by Drug Type, 2022
FIG 6 North America Age Related Macular Degeneration (AMD) Market share by Drug Type, 2030
FIG 7 North America Age Related Macular Degeneration (AMD) Market by Drug Type, 2019 - 2030, USD Million
FIG 8 North America Age Related Macular Degeneration (AMD) Market share by Disease Type, 2022
FIG 9 North America Age Related Macular Degeneration (AMD) Market share by Disease Type, 2030
FIG 10 North America Age Related Macular Degeneration (AMD) Market by Disease Type, 2019 - 2030, USD Million
FIG 11 North America Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2022
FIG 12 North America Age Related Macular Degeneration (AMD) Market share by Distribution Channel, 2030
FIG 13 North America Age Related Macular Degeneration (AMD) Market by Distribution Channel, 2019 - 2030, USD Million
FIG 14 North America Age Related Macular Degeneration (AMD) Market share by Country, 2022
FIG 15 North America Age Related Macular Degeneration (AMD) Market share by Country, 2030
FIG 16 North America Age Related Macular Degeneration (AMD) Market by Country, 2019 - 2030, USD Million
FIG 17 Swot Analysis: Biogen, Inc.
FIG 18 Swot Analysis: Bayer AG
FIG 19 Swot Analysis: Apellis Pharmaceuticals, Inc.
FIG 20 Swot Analysis: Regeneron Pharmaceuticals, Inc.
FIG 21 Swot Analysis: F. Hoffmann-La Roche Ltd.
FIG 22 Swot Analysis: Ionis Pharmaceuticals, Inc.
FIG 23 SWOT Analysis: Novartis AG
FIG 24 Swot Analysis: Sanofi S.A.
FIG 25 Swot Analysis: Coherus Biosciences, Inc.
FIG 26 Swot Analysis: Bausch Health Companies, Inc.
Unique Offerings 